Our physiology engine is built on over 132,000 parameters.
We can run multiple simulations concurrently.
We have the ability to characterise a new molecule, and to administer patient dosages “in-silico” in multiple simulations, and to observe and record responses.
We are not a pharma company, but we understand health and data science. We know that pharma R&D is costly, time consuming and risky. The same is true of clinical trials.
We aim to help reduce these costs by the early identification of low-frequency responses to a new drug. In so doing, we also aim to reduce the risks associated with the clinical programme.
Please get in touch if you would like to discuss collaboration opportunities.